404
Equine Pharmaceuticals And Supplements Market Report
Global Equine Pharmaceuticals and Supplements Market, Trends, Market Analysis
The Global Equine Pharmaceuticals and Supplements Market is segmented By Type (Pharmaceuticals, Supplements), By Distribution Channel (Veterinary Hospitals, Drugstores, and Others), and Region. The report also covers COVID-19 Impact Analysis and Forecast to 2026...
The equine pharmaceutical and supplement market size is expected to reach USD 1,100.5 million in the foreseeable future.
Zoetis (The US), Boehringer Ingelheim (Germany), Merck & Co (The US), Elanco Bayer (The US), Ceva Sante Animale (France), Virbac (France), Vetoquinol (France), Affymetrix (The US), and Celltrion (South Korea) are among the key players in the equine pharmaceuticals and supplement market.
The equine pharmaceuticals and supplements market is expected to grow at an impressive CAGR of 4.2% in the coming years.
Growing awareness regarding equine pharmaceuticals and supplements products and rising demand for herbal feed, digestive, and energy supplements owing to the choice among horse breeders for organic products are some of the factors driving the growth of equine pharmaceuticals and supplements market.
Asia Pacific market garnered a significant market share in 2020 and is projected to grow at a healthy CAGR during the assessment period.
The pharmaceuticals segment is expected to register the fastest CAGR in the equine pharmaceuticals and supplements market in the coming years.
Equine pharmaceuticals and supplements companies, Equine pharmaceuticals and supplements vendors, Horse owners and sellers, Horse riding event organizations, Horse race competition organizations are the target audience in the equine pharmaceuticals and supplements market.